Evidence map›Paper›PMID 41058476›Full record

ArticlemAbs2025

AbDesign: database of point mutants of antibodies with associated structures reveals poor generalization of binding predictions from machine learning models.

Bartosz Janusz, Dawid Chomicz, Samuel Demharter, Marloes Arts, Jurrian de Kanter, Yano Wilke, Helena Britze, Sonia Wrobel, Tomasz Gawłowski, Pawel Dudzic and 4 more

Abstract read
In one paragraph

Article in mAbs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bartosz JanuszR&D, NaturalAntibody, Szczecin, Poland.
Dawid ChomiczR&D, NaturalAntibody, Szczecin, Poland.
Samuel DemharterGenmab BV, Discovery Data Science, Utrecht, Netherlands.
Marloes ArtsGenmab BV, Discovery Data Science, Utrecht, Netherlands.
Jurrian de KanterGenmab BV, Discovery Data Science, Utrecht, Netherlands.
Yano WilkeGenmab BV, Discovery Data Science, Utrecht, Netherlands.
Helena BritzeGenmab BV, Discovery Data Science, Utrecht, Netherlands.
Sonia WrobelR&D, NaturalAntibody, Szczecin, Poland.
Tomasz GawłowskiR&D, NaturalAntibody, Szczecin, Poland.
Pawel DudzicR&D, NaturalAntibody, Szczecin, Poland.
Kärt UkkiviIcosagen Cell Factory OÜ, Tartumaa, Estonia.
Lauri PeilIcosagen Cell Factory OÜ, Tartumaa, Estonia.
Roberto SpreaficoGenmab BV, Discovery Data Science, Utrecht, Netherlands.
Konrad KrawczykR&D, NaturalAntibody, Szczecin, Poland.ORCID 0000-0003-0697-5522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are naturally evolved molecular recognition scaffolds that can bind a variety of surfaces. Their designability is crucial to the development of biologics, with computational methods holding promise in accelerating the delivery of medicines to the clinic. Modeling antibody-antigen recognition is prohibitively difficult, with data paucity being one of the biggest hurdles. Current affinity datasets comprise a small number of experimental measurements, which are often not standardized between molecules. Here, we address these issues by creating a dataset of seven antigens with two antibodies each, for which we introduce a heterogeneous set of mutations to the CDR-H3 measured by ELISA. Each of the parental complexes has a known crystal structure. We perform benchmarking of state-of-the-art affinity prediction algorithms to gauge their effectiveness. Current computational methods exhibit substantial limitations in accurately predicting the effects of single-point mutations. In contrast, the older empirical, physics-based method FoldX performs well in identifying mutants that retain binding. These findings highlight the need for more resources like the one presented here, i.e. large, molecularly diverse, and experimentally consistent datasets.

Indexed as

Machine LearningPoint MutationComplementarity Determining RegionsDatabases, ProteinHumansModels, MolecularComplementarity Determining RegionsAffinity maturationdatabasemachine learningprotein design

Identifiers

PMID41058476
PMCPMC12520099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.